These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 7619052)

  • 1. Variable effects of maturity-onset-diabetes-of-youth (MODY)-associated glucokinase mutations on substrate interactions and stability of the enzyme.
    Liang Y; Kesavan P; Wang LQ; Niswender K; Tanizawa Y; Permutt MA; Magnuson MA; Matschinsky FM
    Biochem J; 1995 Jul; 309 ( Pt 1)(Pt 1):167-73. PubMed ID: 7619052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of glucokinase mutations associated with maturity-onset diabetes of the young type 2 (MODY-2): different glucokinase defects lead to a common phenotype.
    Miller SP; Anand GR; Karschnia EJ; Bell GI; LaPorte DC; Lange AJ
    Diabetes; 1999 Aug; 48(8):1645-51. PubMed ID: 10426385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-biological assessment of human glucokinase mutants causing maturity-onset diabetes of the young type 2 (MODY-2) or glucokinase-linked hyperinsulinaemia (GK-HI).
    Burke CV; Buettger CW; Davis EA; McClane SJ; Matschinsky FM; Raper SE
    Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):345-52. PubMed ID: 10455021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of novel maturity-onset diabetes of the young (MODY)-associated mutations on glucokinase activity and protein stability.
    Galán M; Vincent O; Roncero I; Azriel S; Boix-Pallares P; Delgado-Alvarez E; Díaz-Cadórniga F; Blázquez E; Navas MA
    Biochem J; 2006 Jan; 393(Pt 1):389-96. PubMed ID: 16173921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of glucokinase-MODY mutants to inactivation by oxidative stress in pancreatic β-cells.
    Cullen KS; Matschinsky FM; Agius L; Arden C
    Diabetes; 2011 Dec; 60(12):3175-85. PubMed ID: 22028181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure/function studies of human beta-cell glucokinase. Enzymatic properties of a sequence polymorphism, mutations associated with diabetes, and other site-directed mutants.
    Takeda J; Gidh-Jain M; Xu LZ; Froguel P; Velho G; Vaxillaire M; Cohen D; Shimada F; Makino H; Nishi S
    J Biol Chem; 1993 Jul; 268(20):15200-4. PubMed ID: 8325892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sugar binding to recombinant wild-type and mutant glucokinase monitored by kinetic measurement and tryptophan fluorescence.
    Zelent B; Odili S; Buettger C; Shiota C; Grimsby J; Taub R; Magnuson MA; Vanderkooi JM; Matschinsky FM
    Biochem J; 2008 Jul; 413(2):269-80. PubMed ID: 18370929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dorzagliatin, a Dual-Acting Glucokinase Activator, Increases Insulin Secretion and Glucose Sensitivity in Glucokinase Maturity-Onset Diabetes of the Young and Recent-Onset Type 2 Diabetes.
    Chow E; Wang K; Lim CKP; Tsoi STF; Fan B; Poon E; Luk AOY; Ma RCW; Ferrannini E; Mari A; Chen L; Chan JCN
    Diabetes; 2023 Feb; 72(2):299-308. PubMed ID: 36342518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucokinase mutations associated with non-insulin-dependent (type 2) diabetes mellitus have decreased enzymatic activity: implications for structure/function relationships.
    Gidh-Jain M; Takeda J; Xu LZ; Lange AJ; Vionnet N; Stoffel M; Froguel P; Velho G; Sun F; Cohen D
    Proc Natl Acad Sci U S A; 1993 Mar; 90(5):1932-6. PubMed ID: 8446612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribozyme-mediated attenuation of pancreatic beta-cell glucokinase expression in transgenic mice results in impaired glucose-induced insulin secretion.
    Efrat S; Leiser M; Wu YJ; Fusco-DeMane D; Emran OA; Surana M; Jetton TL; Magnuson MA; Weir G; Fleischer N
    Proc Natl Acad Sci U S A; 1994 Mar; 91(6):2051-5. PubMed ID: 7510884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and analysis of novel R308K mutation in glucokinase of type 2 diabetic patient and its kinetic correlation.
    Yellapu NK; Valasani KR; Pasupuleti SK; Gopal S; Potukuchi Venkata Gurunadha Krishna S; Matcha B
    Biotechnol Appl Biochem; 2014; 61(5):572-81. PubMed ID: 24447076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural instability of mutant beta-cell glucokinase: implications for the molecular pathogenesis of maturity-onset diabetes of the young (type-2).
    Kesavan P; Wang L; Davis E; Cuesta A; Sweet I; Niswender K; Magnuson MA; Matschinsky FM
    Biochem J; 1997 Feb; 322 ( Pt 1)(Pt 1):57-63. PubMed ID: 9078243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GCK-MODY diabetes as a protein misfolding disease: the mutation R275C promotes protein misfolding, self-association and cellular degradation.
    Negahdar M; Aukrust I; Molnes J; Solheim MH; Johansson BB; Sagen JV; Dahl-Jørgensen K; Kulkarni RN; Søvik O; Flatmark T; Njølstad PR; Bjørkhaug L
    Mol Cell Endocrinol; 2014 Jan; 382(1):55-65. PubMed ID: 24001579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization of MODY2 mutations highlights the importance of the fine-tuning of glucokinase and its role in glucose sensing.
    García-Herrero CM; Rubio-Cabezas O; Azriel S; Gutierrez-Nogués A; Aragonés A; Vincent O; Campos-Barros A; Argente J; Navas MA
    PLoS One; 2012; 7(1):e30518. PubMed ID: 22291974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional analysis of human glucokinase gene mutations causing MODY2: exploring the regulatory mechanisms of glucokinase activity.
    García-Herrero CM; Galán M; Vincent O; Flández B; Gargallo M; Delgado-Alvarez E; Blázquez E; Navas MA
    Diabetologia; 2007 Feb; 50(2):325-33. PubMed ID: 17186219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal model for maturity-onset diabetes of the young generated by disruption of the mouse glucokinase gene.
    Bali D; Svetlanov A; Lee HW; Fusco-DeMane D; Leiser M; Li B; Barzilai N; Surana M; Hou H; Fleischer N
    J Biol Chem; 1995 Sep; 270(37):21464-7. PubMed ID: 7665557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose regulates the maximal velocities of glucokinase and glucose utilization in the immature fetal rat pancreatic islet.
    Tu J; Tuch BE
    Diabetes; 1996 Aug; 45(8):1068-75. PubMed ID: 8690154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human beta-cell glucokinase. Dual role of Ser-151 in catalysis and hexose affinity.
    Xu LZ; Harrison RW; Weber IT; Pilkis SJ
    J Biol Chem; 1995 Apr; 270(17):9939-46. PubMed ID: 7730377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three novel missense mutations in the glucokinase gene (G80S; E221K; G227C) in Italian subjects with maturity-onset diabetes of the young (MODY). Mutations in brief no. 162. Online.
    Guazzini B; Gaffi D; Mainieri D; Multari G; Cordera R; Bertolini S; Pozza G; Meschi F; Barbetti F
    Hum Mutat; 1998; 12(2):136. PubMed ID: 10694920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of leptin receptors in pancreatic islets of Zucker diabetic fatty rats restores GLUT-2, glucokinase, and glucose-stimulated insulin secretion.
    Wang MY; Koyama K; Shimabukuro M; Mangelsdorf D; Newgard CB; Unger RH
    Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11921-6. PubMed ID: 9751766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.